Crohn's disease management after intestinal resection: a randomised trial

Area of Science:

• Gastroenterology
• Surgical Oncology
• Clinical Trial Research

Background:

• Crohn's disease often necessitates intestinal resection, yet recurrence is common, leading to further surgeries.
• Identifying optimal strategies to prevent postoperative recurrence is crucial for patient management.

Purpose of the Study:

• To evaluate the efficacy of an active care strategy involving early colonoscopy and treatment adjustment versus standard care in preventing postoperative Crohn's disease recurrence.

Main Methods:

• A randomized trial involving 174 patients undergoing intestinal resection for Crohn's disease.
• Patients received initial therapy (metronidazole, with thiopurine or adalimumab for high-risk individuals).
• Randomization to either active care (colonoscopy at 6 months with treatment step-up for recurrence) or standard care (no routine colonoscopy).

Main Results:

• Endoscopic recurrence at 18 months was significantly lower in the active care group (49%) compared to standard care (67%).
• Complete mucosal normality was achieved more frequently in the active care group (22% vs 8%).
• Smoking and multiple clinical risk factors were associated with increased recurrence risk.

Conclusions:

• An active care approach, incorporating early endoscopic assessment and tailored treatment escalation, is superior to conventional therapy for preventing postoperative Crohn's disease recurrence.
• Selective immune suppression adjusted for early recurrence, rather than routine use, aids disease control.
• Ongoing monitoring is essential, even for low-risk patients or those achieving initial remission.